Dana-Farber Researchers Create Experimental AI-based Oncologist’s Assistant
On Jan. 20, 2026, Dana-Farber researchers announced developing an AI-based oncologist’s assistant that shows the potential for AI…
Biotechnology | Clinical Research | Diagnostics | FDA | Genomics | Infectious Disease | Medical Device | Medicine | Non-Profit Research | Oncology | Ophthalmogy | Organ Transplant | Pharmaceutical | Rare Disease | Therapeutics | U.S. Congress | Vaccine | Women's Health
U.S. healthcare spending soars to over $5 trillion in 2024
On Jan. 14, 2026, U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion…
AI model built by Yale and Google team finds new way to treat cancer
On Jan. 13, 2026, collaborating with Google’s top artificial intelligence labs, a team of Yale researchers announced they…
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS(TM) Patient
On Jan. 13, 2026, BriaCell Therapeutics announces the durable and sustained complete resolution of a lung metastasis in…
Diagnostics | Disease | Medical Device | Medicine | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics | U.S. Congress | Women's Health
American Cancer Society Reports a Milestone 70 Percent 5-Year Survival Rate for all Cancers Combined
On Jan. 13, 2026, The American Cancer Society (ACS) released Cancer Statistics, 2026, the organization’s annual report on cancer facts and trends. The findings show, for…
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida
On Jan. 9, 2026, Novartis announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in…
Mount Sinai Researchers Help Create Largest Immune Cell Atlas of Bone Marrow in Multiple Myeloma Patients
On Jan. 9, 2026, scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research…
Stem cell engineering breakthrough paves way for next-generation living drugs
On Jan. 8, 2026, for the first time, researchers at the University of British Columbia have demonstrated how…
Biology | Diagnostics | Disease | Oncology | Therapeutics
New research uncovers critical DNA repair mechanism during cell division
On Jan. 8, 2026, a major advance in cell biology has revealed how our cells safeguard their genetic…
Diagnostics | Environmental | EPA | Forestry | Infectious Disease | Non-Profit Research | Oncology | Therapeutics
respiratory infections remain the world’s leading infectious cause of death
On Jan. 6, 2026, a systematic analysis for the Global Burden of Disease Global study shows that lower…
Some antibodies outmaneuver germs from sticking to cells
On Jan. 6, 2026, a study led by University of Washington School of Medicine researchers uncovered several new…
Space Station Research Supports New FDA-Approved Cancer Therapy
On Dec. 18, 2025, the National Aeronautics and Space Administration (NASA) announced it has opened the International Space…
GigaTIME AI tool advances cancer research and could unlock access to better treatment
On Dec. 15, 2025, Microsoft Research announced a new AI tool developed by and published in Cell allows…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
UCLA team discovers how to target ‘undruggable’ protein that fuels aggressive leukemia
On Dec. 9, 2025, researchers at the UCLA Health Jonsson Comprehensive Cancer Center announced they have identified a…
Agriculture | Artificial Intelligence | Biotechnology | Forestry | Genomics | Infectious Disease | Nanotechnology | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Stem Cell | Therapeutics | Vaccine
Canada launches $1.7 billion initiative to recruit world-leading researchers
On Dec. 9, 2025, officials from the Canada Economic Development for Quebec Regions, and the Minister of Industry,…
Race, Ethnicity and Donor Type Continue to Affect Survival After Donor Stem Cell Transplant
On Dec. 8, 2025, a study led by Roswell Park Comprehensive Cancer Center reveals that a patient’s race…
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer
On Nov. 24, 2025, a new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy…
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
CPRIT approves $154 million in new cancer research and prevention awards, surpasses $4 billion total
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
Novartis announces plans to build flagship manufacturing hub in North Carolina
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
Artificial Intelligence | Biotechnology | Energy | Environmental | Forestry | Genomics | Infectious Disease | Nanotechnology | Neurology | Oncology | Pharmaceutical | Therapeutics | Vaccine
China’s new scientist visa is a ‘serious bid’ for the world’s top talent
On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
Artificial Intelligence | Biotechnology | Chemistry | Energy | Genomics | Infectious Disease | Medical Device | Neurology | Oncology | Pharmaceutical | Stem Cell | Therapeutics | Vaccine
Leiden Report Show Universities in China Dominate Top Ten Rankings
On Oct. 29, 2025, the CWTS Leiden ranking show that Harvard University dropped to third place in the…
Lilly announces $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the U.S.
On Oct. 29, 2025, Eli Lilly announced a planned investment of more than $1.2 billion to expand and…
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
On Oct. 23, 2025, GSK announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf)…
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…